Could a smart bra help spot breast cancer early?
NCT ID NCT05294016
First seen Jun 27, 2026 · Last updated Jun 27, 2026
Summary
This pilot study tests a smart bra that measures skin temperature to find breast abnormalities, including cancer. About 70 women with or without breast cancer will wear the device to see how well it detects tumors. If it works, it could offer a simple, portable screening option.
What this could mean
Our plain-language read of the trial. This is informational only — not medical advice or a prediction.
Active substance
BRA CONNECT device (a smart bra that measures skin temperature)
What this could lead to
If successful, this could lead to a non-invasive, portable tool for earlier breast cancer detection, potentially improving screening access.
What could go wrong
This is a small pilot study with only 70 participants, so results may not apply to everyone. The device is still experimental and may not be accurate enough for widespread use.
Disclaimer
Read more
Show less
This is a summary of
the original study
.
Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes no responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
This is a summary of the original study . Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes no responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
Get updates
Get notified about this study
Sign up to get updates when this study changes or when new studies for BREAST CANCER are added.
By submitting, you agree to our Terms of use
Conditions
The condition(s) this trial relates to.
As listed by the trial registrant
The condition terms exactly as the trial's registrant entered them.
Contacts and locations
Show contact details
Enter your email to view the contact information for this study.
By submitting, you agree to our Terms of use
Locations
-
Hôpital Nord Franche-Comté
Trévenans, France
-
ICANS (Institut de Cancérologie de Strasbourg)
Strasbourg, France